Holy Stone Healthcare Co., Ltd. (TPEX:4194)
5.20
-0.60 (-10.34%)
Nov 20, 2026, 1:48 PM CST
Holy Stone Healthcare Market Cap
Holy Stone Healthcare has a market cap or net worth of 759.06 million as of November 20, 2026. It is the 35,290th most valuable company in the world and the 2,091st biggest in Taiwan. Its market cap has decreased by 42.29% in one year.
Market Cap
759.06M
Enterprise Value
690.72M
Revenue
n/a
Global Rank
Country Rank
#2,091 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 13, 2013, Holy Stone Healthcare's market cap has decreased from 5.54B to 759.06M, a decrease of -86.31%. That is a compound annual growth rate of -14.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 773.66M | -31.17% |
| Dec 31, 2025 | 1.12B | -40.54% |
| Dec 31, 2024 | 1.89B | -21.47% |
| Dec 29, 2023 | 2.41B | -36.56% |
| Dec 30, 2022 | 3.79B | 20.29% |
| Dec 30, 2021 | 3.15B | 17.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enimmune | 981.02M |
| Bio Preventive Medicine | 959.30M |
| Level Biotechnology | 921.66M |
| BiOptic | 866.92M |
| TCI GENE | 859.90M |
| Lukas Biomedical | 789.33M |
| BioLASCO Taiwan | 718.42M |
| GeneReach Biotechnology | 693.67M |